Metsera Tumbles After Novo Pulls Out of Bidding War With Pfizer

Watch Scarlet and Paul LIVE every day on YouTube: http://bit.ly/3vTiACF . Bloomberg Intelligence hosted by Paul Sweeney and Scarlet Fu -Sam Fazeli, Bloomberg Intelligence, Director of Research for Global Industries and Senior Pharmaceuticals, discusses Metsera declining to further raise its offer for the US maker of an experimental weight-loss drug, bringing a bidding war with Pfizer Inc. to an end. Novo Nordisk A/S decided to drop out of the running for Metsera after Pfizer matched its latest offer and Metsera said it got a call from the US Federal Trade Commission flagging potential regulatory risks with the proposed Novo deal structure. -Mandeep Singh, Global Tech Research Head at Bloomberg Intelligence, discusses the top tech stories. Taiwan Semiconductor Manufacturing Co. reported a 16.9% rise in sales for October, the slowest pace since February 2024. Separately, Nvidia Corp. Chief Executive Officer Jensen Huang said he had asked Taiwan Semiconductor Manufacturing Co. for more chip supplies as artificial intelligence demand remains strong. -Jennifer Bartashus, Bloomberg Intelligence Senior Analyst, Retail Staples & Packaged Food, discusses Tyson Foods saying it expects profits to be little changed next year as its beef segment continues to lose money. The company's beef segment is expected to see an adjusted operating loss due to a severe cattle shortage that has driven up prices and constrained volumes. See omnystudio.com/listener for privacy information.